T-dm1
Hi Eric,
I'm quite sure my idea won't work, but at this stage everything is worth trying. It is not clear to me that Caryn really progressed when she was on the TDM1 trial. She was also on a high dose. This is a very effective drug for some patients and she may not have had the opportunity to receive the enough treatments to help her. The drug companies are very strict, but maybe her trial doctor would be willing to fight for her to be placed with a lower dose back on the trial with this new development.
You and Caryn continue to be in my thoughts.
Barbara H.
|